Newbridge Financial Services Group’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05K | Sell |
3,000
-500
| -14% | -$341 | ﹤0.01% | 1136 |
|
|
2025
Q1 | $3.19K | Buy |
3,500
+500
| +17% | +$456 | ﹤0.01% | 845 |
|
|
2024
Q4 | $3.27K | Hold |
3,000
| – | – | ﹤0.01% | 913 |
|
|
2024
Q3 | $2.27K | Hold |
3,000
| – | – | ﹤0.01% | 558 |
|
|
2024
Q2 | $3.72K | Hold |
3,000
| – | – | ﹤0.01% | 888 |
|
|
2024
Q1 | $5.67K | Hold |
3,000
| – | – | ﹤0.01% | 868 |
|
|
2023
Q4 | $7.92K | Sell |
3,000
-1,000
| -25% | -$2.64K | ﹤0.01% | 789 |
|
|
2023
Q3 | $9.2K | Sell |
4,000
-1,000
| -20% | -$2.3K | ﹤0.01% | 836 |
|
|
2023
Q2 | $18.3K | Hold |
5,000
| – | – | 0.01% | 722 |
|
|
2023
Q1 | $17.9K | Sell |
5,000
-12,000
| -71% | -$42.8K | 0.01% | 766 |
|
|
2022
Q4 | $48.5K | Hold |
17,000
| – | – | 0.03% | 472 |
|
|
2022
Q3 | $38K | Buy |
17,000
+5,000
| +42% | +$11.2K | 0.02% | 518 |
|
|
2022
Q2 | $30K | Buy |
12,000
+8,000
| +200% | +$20K | 0.02% | 534 |
|
|
2022
Q1 | $20K | Hold |
4,000
| – | – | 0.01% | 730 |
|
|
2021
Q4 | $45K | Hold |
4,000
| – | – | 0.02% | 489 |
|
|
2021
Q3 | $58K | Hold |
4,000
| – | – | 0.04% | 373 |
|
|
2021
Q2 | $47K | Hold |
4,000
| – | – | 0.03% | 456 |
|
|
2021
Q1 | $49K | Hold |
4,000
| – | – | 0.04% | 403 |
|
|
2020
Q4 | $50K | Hold |
4,000
| – | – | 0.04% | 334 |
|
|
2020
Q3 | $60K | Buy |
+4,000
| New | +$60K | 0.06% | 283 |
|